Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,619.00    -20.00 (-0.76%)
Bid:
2,621.00
Ask:
2,625.00
Spread: 4.00 (0.153%)
Market Cap: £23.39b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Directorate Changes

19 Jan 2022 07:00

RNS Number : 8753Y
Experian plc
19 January 2022
Β 

Directorate Changes

Β 

19 January 2022 ─ Experian, the global information services company, today announces that after 19 years at Experian, Kerry Williams has notified the Company of his intention to retire as Chief Operating Officer and as an Executive Director of the Company. To ensure a smooth succession process, Kerry will remain with Experian through to 31 March 2023.

Β 

Craig Boundy will succeed Kerry Williams. Craig has successfully led Experian's North America region for seven years, having joined Experian in November 2011 to lead the UK & Ireland region, and operated in a variety of leading management positions. Craig will assume the position of Chief Operating Officer on 1 April 2022 and will join the Board as an Executive Director of the Company from the conclusion of the Company's AGM in July 2022, when Kerry will step down from the Board.

Β 

Jennifer Schulz will assume the role of CEO, North America for Experian from 1 April 2022. Jennifer joined Experian in 2013 and is currently Group President of our North America Health and Automotive businesses and global Targeting and Data Quality (EDQ) businesses.

Β 

Mike Rogers, Experian's Chairman said "Experian has made tremendous progress over the past few years and we are immensely grateful to Kerry for his outstanding contribution to this success. Craig's commercial and operational expertise, as well as his commitment to fostering diversity, equity and inclusion within Experian, will bring equally deep knowledge and perspectives to the Experian plc Board."

Β 

Brian Cassin, Experian's Chief Executive Officer said "Kerry, Craig and Jennifer are extraordinary leaders and we are fortunate to have access to talent of this calibre so widely across Experian. Kerry has played a pivotal role in taking the business to the strong position it is in today. We thank him for this and wish him well for his retirement. Craig and Jennifer will build on these strong foundations as we progress our journey of innovation-led growth and I look forward to continuing to work closely with them in the years to come."

Β 

The Company confirms that there are no details to be disclosed under Listing Rule 9.6.13R, paragraphs (1) to (6) in respect of the appointment of Craig Boundy as an Executive Director of the Company from the conclusion of the Company's AGM in July 2022.

Β 

Contact:

Experian

Nadia Ridout-Jamieson Investor queries +44 (0)20 3042 4278

Gerry Tschopp Media queries

Β 

Tulchan

Graeme Wilson, Louise Male and Guy Bates +44 (0)20 7353 4200

Β 

About Experian

Experian is the world's leading global information services company. During life's big moments - from buying a home or a car, to sending a child to college, to growing a business by connecting with new customers - we empower consumers and our clients to manage their data with confidence. We help individuals to take financial control and access financial services, businesses to make smarter decisions and thrive, lenders to lend more responsibly, and organisations to prevent identity fraud and crime.

Β 

We have 20,000 people operating across 44 countries and every day we're investing in new technologies, talented people, and innovation to help all our clients maximise every opportunity. We are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.

Β 

Learn more at www.experianplc.com or visit our global content hub at our global news blog for the latest news and insights from the Group.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAUWAWRUWUAAAR
Date   Source Headline
7th Aug 20249:34 amRNSDirector/PDMR Shareholding
31st Jul 202410:59 amRNSTotal Voting Rights
23rd Jul 202410:13 amRNSDirector/PDMR Shareholding
17th Jul 202411:15 amRNSResult of AGM
16th Jul 20247:00 amRNSDirectorate Change
16th Jul 20247:00 amRNSTrading update, first quarter
28th Jun 20245:35 pmRNSSecond interim dividend
28th Jun 20243:10 pmRNSTotal Voting Rights
27th Jun 20249:15 amRNSDirector/PDMR Shareholding
17th Jun 20244:00 pmRNSDirector/PDMR Shareholding
12th Jun 202411:30 amRNSDirector/PDMR Shareholding
7th Jun 20241:34 pmRNSAnnual Financial Report
31st May 20244:12 pmRNSTotal Voting Rights
31st May 20249:36 amRNSElections for Second Interim Dividend
23rd May 20245:30 pmRNSHolding(s) in Company
15th May 20241:30 pmRNSShare repurchases
15th May 20247:00 amRNSFull-year financial report
30th Apr 20245:24 pmRNSTransaction in Own Shares
30th Apr 202411:22 amRNSTotal Voting Rights
29th Apr 20245:52 pmRNSTransaction in Own Shares
26th Apr 20245:19 pmRNSTransaction in Own Shares
25th Apr 20245:16 pmRNSTransaction in Own Shares
24th Apr 20245:14 pmRNSTransaction in Own Shares
23rd Apr 20245:28 pmRNSTransaction in Own Shares
22nd Apr 20245:34 pmRNSTransaction in Own Shares
19th Apr 20245:42 pmRNSTransaction in Own Shares
18th Apr 20245:41 pmRNSTransaction in Own Shares
17th Apr 20245:21 pmRNSTransaction in Own Shares
16th Apr 20245:40 pmRNSTransaction in Own Shares
15th Apr 20245:39 pmRNSTransaction in Own Shares
12th Apr 20246:00 pmRNSTransaction in Own Shares
11th Apr 20245:42 pmRNSTransaction in Own Shares
10th Apr 20245:44 pmRNSTransaction in Own Shares
10th Apr 20249:45 amRNSAdditional Listing
9th Apr 20246:04 pmRNSTransaction in Own Shares
8th Apr 20246:14 pmRNSTransaction in Own Shares
8th Apr 20247:54 amRNSShare repurchase programme
4th Apr 20246:00 pmRNSExperian to acquire Illion in ANZ
3rd Apr 20249:30 amRNSDirector/PDMR Shareholding
28th Mar 202411:05 amRNSTotal Voting Rights
21st Mar 202412:15 pmRNSBlock listing Interim Review
20th Mar 20248:47 amRNSAdditional Listing
14th Mar 20242:08 pmRNSAdditional Listing
6th Mar 20249:15 amRNSAdditional Listing
4th Mar 202411:45 amRNSExperian signs new Revolving Credit Facility
29th Feb 202411:30 amRNSTotal Voting Rights
28th Feb 202410:15 amRNSDirector/PDMR Shareholding
28th Feb 20249:15 amRNSAdditional Listing
21st Feb 20249:15 amRNSAdditional Listing
14th Feb 20249:15 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.